LNK-754

DRUG2 trials

Sponsors

Link Medicine Corporation

Conditions

Healthy Elderly VolunteersMild Alzheimer's Disease

Phase 1

A Double-Blind, Placebo Controlled, Single, Escalating Dose Study to Evaluate the Preliminary Pharmacokinetics, Safety and Tolerability of LNK-754 in Healthy Elderly Volunteers

CompletedNCT00903253

Link Medicine CorporationHealthy Elderly Volunteers

Start: 2009-05-31End: 2009-09-30Target: 40Updated: 2009-09-10

An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease

CompletedNCT01013610

Link Medicine CorporationMild Alzheimer's Disease

Start: 2009-11-30End: 2011-03-31Target: 110Updated: 2011-03-15